Chinook Therapeutics U.S
Seattle, US · Founded 2018 · Delaware corporation · 2 known investors
Founders & leadership
ED
Eric DobmeierExecutive
SH
Sam HallNamed on SEC filing
Board
SA
JC
JD
Investors · 2
Reported raises · per SEC filings
Form D private placements$180M disclosed across 2 rounds · 2019–2020
▶$115MraisedOct 2020 · 25 investors · BiotechnologyRule 506(b)
▶$115MraisedOct 2020 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeremy CaldwellDirector
- Jerel DavisDirector
- Andrew KingExecutive Officer
- Tom FrolichExecutive Officer
- Preston KlassenDirector
- Eric DobmeierExecutive Officer, Director
- Paul EisenbergDirector
- Srinivas AkkarajuDirector
- Alan GlicklichExecutive Officer
- Offering amount
- $115M
- Amount sold
- $115M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$65MraisedAug 2019 · 5 investors · Other TechnologyRule 506(b)
▶$65MraisedAug 2019 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Srini AkkarajuDirector
- Jeremy CaldwellDirector
- Jerel DavisDirector
- Sam HallDirector
- Eric DobmeierExecutive Officer, Director
- Offering amount
- $65M
- Amount sold
- $65M
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Chinook Therapeutics U.S's investors?
- Chinook Therapeutics U.S's investors include Samsara BioCapital, Versant Ventures.
- How much funding has Chinook Therapeutics U.S raised?
- Chinook Therapeutics U.S has disclosed $180M raised across 2 rounds.
- Where is Chinook Therapeutics U.S headquartered?
- Chinook Therapeutics U.S is headquartered in Seattle, US.